INDEPENDENT MODEL VALIDATION OF RMCAP AND CCAP Solicitation ID/Procurement Identifier: 86615720R00021 Ultimate Completion Date: Mon Dec 09 18:00:00 GMT 2024
Supplier: SMITHKLINE-BEECHAM PHARMACEUTICALS - GLAXOSMITHKLINE PHARMACEUTICALS Contract Amount: Organizations: State of Arizona Commodity: Drugs and Pharmaceutical Products PR/Order itemsLabelProduct CodeNegotiated Price CurrencyUOMPharmaceuticalsCTR059473-1USDEA
CMP TASK ORDER FOR OCIO CTRS-COE-POC FROM THE CMP BPA Solicitation ID/Procurement Identifier: 1605DC18A0044 Ultimate Completion Date: Tue Sep 24 17:00:00 GMT 2024
RMCH BPA 1/1/2023 - 12/31/2023 Solicitation ID/Procurement Identifier: 75H71023P00332 Ultimate Completion Date: Tue Dec 31 18:00:00 GMT 2024
CMAT Solicitation ID/Procurement Identifier: FA875018S7005 Ultimate Completion Date: Fri Nov 29 18:00:00 GMT 2024
CONTINUATION SHEET REFERENCE NO. OF DOCUMENT BEING CONTINUED: CONTINUED ON NEXT PAGE PAGE 5 OF 28 PAGES SPE7L4-23-T-6527 SECTION A REPRESENTATION. Caution Notice: Offerors are required to comply with domestic material restrictions. The Berry Amendment, the Buy American Act, and other domestic material restrictions may apply. Offerors are instructed to refer to the solicitation clauses related to foreign sourcing for more information on applicability. The Berry Amendment threshold has been reduced to $150,000 and vendors must carefully review related clauses DFARS 252.225-7006, 252.225-7012, and 252.225-7015 for applicability requirements. If your offer is based on a non-domestic material, you are required to provide dis...
